LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Начало・Списък с акции・Cencora Inc

Cencora Inc

Затворен

СекторЗдравеопазване

370.83 1.17

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

369.63

Максимум

373.91

Ключови измерители
By Trading Economics
Приходи	906M 566M
Продажби	2.2B 86B
P/E Средно за сектора	43.836 108.767
EPS	2.87
Дивидентна доходност	0.62
Марж на печалбата	0.659
Служители	47,000
EBITDA	858M 1B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+14.14% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.62% 2.21%
Следващи печалби	6.05.2026 г.
Следваща дата на дивидент	2.03.2026 г.
Следваща дата на екс-дивидент	15.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	482M 71B
Предишно отваряне	369.66
Предишно затваряне	370.83

Настроения в новините

By Acuity

34%

66%

80 / 352 Класиране в Healthcare

Cencora Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

27.02.2026 г., 23:53 ч. UTC

Горещи акции

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27.02.2026 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

27.02.2026 г., 17:55 ч. UTC

Горещи акции

Toronto Stocks Decline, But Remain On Track for Weekly Gains

27.02.2026 г., 23:46 ч. UTC

Придобивния, сливания и поглъщания

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27.02.2026 г., 23:33 ч. UTC

Придобивния, сливания и поглъщания

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

27.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

27.02.2026 г., 21:30 ч. UTC

Печалби

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27.02.2026 г., 21:30 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27.02.2026 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27.02.2026 г., 21:17 ч. UTC

Печалби

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27.02.2026 г., 21:10 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27.02.2026 г., 21:09 ч. UTC

Придобивния, сливания и поглъщания

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27.02.2026 г., 21:00 ч. UTC

Печалби

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27.02.2026 г., 20:31 ч. UTC

Придобивния, сливания и поглъщания

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27.02.2026 г., 20:24 ч. UTC

Пазарно говорене

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27.02.2026 г., 20:23 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27.02.2026 г., 20:12 ч. UTC

Пазарно говорене

Nike Seen With Further Challenges in China -- Market Talk

27.02.2026 г., 19:44 ч. UTC

Пазарно говорене

Gold Caps Historic Month -- Market Talk

27.02.2026 г., 19:39 ч. UTC

Печалби

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27.02.2026 г., 19:38 ч. UTC

Печалби

Earnings Could Push the Stock Market Higher. Too Bad About Everything Else. -- Barrons.com

27.02.2026 г., 18:53 ч. UTC

Придобивния, сливания и поглъщания

Largest U.S. Pension Takes Stake in a Hot Semi Stock, Buys More Nvidia and IonQ -- Barrons.com

27.02.2026 г., 18:45 ч. UTC

Печалби

Quantum Computing Is No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

27.02.2026 г., 18:45 ч. UTC

Пазарно говорене

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

27.02.2026 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

27.02.2026 г., 17:07 ч. UTC

Печалби

Pemex Cuts 4Q Loss As Operating Results Improve

27.02.2026 г., 17:00 ч. UTC

Пазарно говорене

Corn Rides Oil Momentum Higher -- Market Talk

27.02.2026 г., 16:31 ч. UTC

Пазарно говорене

Canadian Economy Shows Resilience -- Market Talk

27.02.2026 г., 16:17 ч. UTC

Пазарно говорене

Canada Economy is Struggling But More Rate Cuts Still a Long Shot -- Market Talk

27.02.2026 г., 15:49 ч. UTC

Печалби

Quantum Computing No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Cencora Inc Прогноза

Ценова цел

By TipRanks

14.14% нагоре

12-месечна прогноза

Среден 418.5 USD 14.14%

Висок 440 USD

Нисък 400 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Cencora Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

9 ratings

Купи

Задържане

Продай

Според 9 анализатори, дали борсови рейтинги на Cencora Inc през последните 3 месеца.

Настроение

By Acuity

80 / 352 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.